Contrast medium dose-to-GFR ratio:: A measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention

被引:101
作者
Nyman, U. [1 ,2 ,3 ,4 ]
Bjork, J. [1 ,2 ,3 ,4 ]
Aspelin, P. [1 ,2 ,3 ,4 ]
Marenzi, G. [1 ,2 ,3 ,4 ]
机构
[1] Lund Univ, Dept Diagnost Radiol, SE-23185 Trelleborg, Sweden
[2] Lund Univ, Univ Hosp, Competence Ctr Clin Res, Lund, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Div Radiol, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden
[4] Univ Milan, Inst Cardiol, IRCCS, Ctr Cardiol Monzino, Milan, Italy
关键词
contrast medium; coronary intervention; glomerular filtration rate; nephropathy; renal insufficiency;
D O I
10.1080/02841850802050762
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The contrast medium (CM) dose-to-eGFR (estimated glomerular filtration rate) ratio has recently been advocated to express systemic exposure to CM in assessing the risk of contrast medium-induced nephropathy (CIN). Purpose: To evaluate how CIN risk might vary with decreasing eGFR at fixed CM-dose/eGFR ratios and other CIN risk factors, and to find a relatively safe CM-dose/eGFR ratio. Material and Methods: 391 patients underwent primary coronary angioplasty for ST-segment elevation acute myocardial infarction. CM dose (grams iodine; g I), eGFR (ml/min), and preprocedural CIN risk factors were entered into a multiple logistic regression model. From the established statistical model, the probability of CIN (>= 44.2 mu mol/1 serum creatinine rise or oliguria/anuria) was calculated at various eGFR levels based on g-I/eGFR ratios of 1: 2, 1: 1, 2: 1, and 3: 1. Results: At a g-I/eGFR ratio <1 the risk of CIN was 3%, while it was 25% at a g-I/eGFR ratio >= 1. Independent predictors of CIN were CM dose, eGFR, left ventricular ejection fraction (LVEF) and cardiogenic shock (ROC area=0.87). An estimated CIN risk of 10% would for example occur at a g-I/eGFR ratio of 1.5:1 in patients with 50% LVEF without shock. At a 1: 2, 1: 1, 2: 1, and 3: 1 g-I/eGFR ratio with 50% LVEF without shock, the CIN risk was about 2, 6, 18, and 30%, respectively, over a wide range of eGFR values (30-90 ml/min). At a 1: 1 g-I/eGFR ratio with 50% LVEF + shock, 25% LVEF without shock, or 25% LVEF + shock, the CIN risk was 20, 55, and 80%, respectively. Conclusion: Relating CM dose to eGFR appears to be an attractive pharmacotoxic model to assess CIN risk. At fixed CM-dose/eGFR ratios, CIN risk increased marginally with decreasing eGFR. Limiting the CM dose in g I numerically to the eGFR value in ml/min or less may be relatively safe with regard to CIN, unless multiple risk factors are present.
引用
收藏
页码:658 / 667
页数:10
相关论文
共 33 条
[1]   Use of the contrast volume to estimated creatinine clearance ratio to predict renal failure after angiography [J].
Altmann, DB ;
Zwas, D ;
Spatz, A ;
Bergman, G ;
Spokojny, A ;
Riva, S ;
Sanborn, TA .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1997, 10 (02) :113-119
[2]  
[Anonymous], 2002, Am J Kidney Dis
[3]   Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification [J].
Bartholomew, BA ;
Harjai, KJ ;
Dukkipati, S ;
Boura, JA ;
Yerkey, MW ;
Glazier, S ;
Grines, CL ;
O'Neill, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) :1515-1519
[4]   Prediction of relative glomerular filtration rate in adults:: New improved equations based on Swedish Caucasians and standardized plasma-creatinine assays [J].
Bjork, J. ;
Back, S. -E. ;
Sterner, G. ;
Carlson, J. ;
Lindstrom, V. ;
Bakoush, O. ;
Simonsson, P. ;
Grubb, A. ;
Nyman, U. .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (07) :678-695
[5]   Measures of exposure versus measures of rate and extent of absorption [J].
Chen, ML ;
Lesko, L ;
Williams, RL .
CLINICAL PHARMACOKINETICS, 2001, 40 (08) :565-572
[6]   DOSING OF CONTRAST MATERIAL TO PREVENT CONTRAST NEPHROPATHY IN PATIENTS WITH RENAL-DISEASE [J].
CIGARROA, RG ;
LANGE, RA ;
WILLIAMS, RH ;
HILLIS, LD .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (06) :649-652
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]   Screening for renal disease using serum creatinine: who are we missing? [J].
Duncan, L ;
Heathcote, J ;
Djurdjev, O ;
Levin, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (05) :1042-1046
[9]  
ELMSTAHL B, 2006, LUND U FM DOCTORIAL, P9
[10]   Contrast media as markers of GFR [J].
Frennby, B ;
Sterner, G .
EUROPEAN RADIOLOGY, 2002, 12 (02) :475-484